anhydrous

CI 972 anhydrous is an inhibitor of purine nucleoside phosphorylase (PNP) (Ki: 0.83 μM) used as a T cell-selective immunosuppressive agent.

Cilazapril is an angiotensin-converting enzyme inhibitor. It has been researched for mild to moderate essential hypertension.

LY2140023 has the potential for schizophrenia.LY2140023 is an orally active prodrug of LY404039. LY404039 is a selective metabotropic glutamate 2/3 receptor agonist.

Isoproterenol sulfate anhydrous is a useful alkaloid. It is used for biological research.

Napsagatran anhydrous is a compound that inhibits the production of both exogenous and endogenous thrombin.

Lixazinone sulfate anhydrous is an inhibitor of cyclic adenosine monophosphate phosphodiesterase (cAMP PDE) and acts as a cardiac enhancer.

Tifurac sodium anhydrous is a derivative of benzofuran acetic acid, possessing analgesic, anti-inflammatory, and antipyretic properties.

KB 5492 is an agent of anti-ulcer. It preventing cysteamine-induced duodenal ulcers by stimulating duodenal HCO3- secretion.

Advantame anhydrous is a non-caloric sweetener, synthesized from isovanillin and aspartame. The U.S. Food and Drug Administration has approved Advantame for general use in foods and beverages except for meat and poultry as a food additive.

MBX-8025 lysine anhydrous is a selective PPAR-delta agonist.

Maropitant citrate anhydrous is a neurokinin (NK1) receptor antagonist.

Mioflazine hydrochloride anhydrous is a nucleoside transport inhibitor that acts on adenosine to improve sleep.

Methyldopa anhydrous is a Central alpha-2 Adrenergic Agonist. The mechanism of action of methyldopa anhydrous is as an Adrenergic alpha2-Agonist.

Mitapivat sulfate anhydrous is an allosteric activator of Pyruvate Kinase (PK) that may be useful in the treatment of Pyruvate Kinase Deficiency.

Fimasartan potassium anhydrous is a non-peptide angiotensin II receptor antagonist (ARB) used for the treatment of hypertension and heart failure.

Tacrolimus anhydrous 8-epimer is a new l-pipecolic acid macrolide lactone, an important immunosuppressive drug that blocks T cell proliferation in vitro by inhibiting the generation of several lymphokines, especially IL-2.

Azumolene sodium anhydrous is a muscle relaxant that inhibits the release of calcium from skeletal muscle sarcoplasmic reticulum. Azumolene inhibits a component of store-operated calcium entry coupled to the skeletal muscle ryanodine receptor. Azumolene, an equipotent dantrolene analog, inhibits a component of SOCE coupled to activation of RyR1 by caffeine and ryanodine, whereas the SOCE component induced by thapsigargin is not affected.

Anhydrous calcium sulfate (97%) [Gypsum ustum (97%)] is suitable for use in medical materials. It can also serve as a biomaterial or an organic compound for life science research.

Sodium sulfate anhydrous (Disodium sulfate) is widely used as a drying agent in biochemical experiments and as a pH regulator. It meets the pharmaceutical-grade standards of the United States Pharmacopeia (USP).

Anhydrous potassium carbonate, 99.995% metals basis is a biochemical reagent that can be used as a biomaterial for life science related research and as a sulfonylation reagent for organic synthesis and drug discovery.

Enolicam (CGS 5391B) is a non-steroidal anti-inflammatory drug that inhibits both cyclooxygenase and lipoxygenase activities.

AW 142446 (Clodazon) is an antidepressant compound.

Piquindone is an antipsychotic compound derived from pyrroloisoquinoline that binds to dopamine D2 receptors.

Ulodesine (also known as BCX4208) is a purine nucleotide phosphorylase (PNP) inhibitor being developed by Biocryst for the treatment of gout. Intended as a once-daily oral therapy, it functions by impacting the purine metabolic pathway upstream of xanthine oxidase to decrease serum uric acid (sUA) levels. Its half-maximal inhibitory concentration (IC(50)) for PNP is 0.5 nM. Currently, BCX-4208 is in early clinical trials to evaluate its potential benefits in treating psoriasis and gout.